Search

Your search keyword '"Ghia A"' showing total 8,937 results

Search Constraints

Start Over You searched for: Author "Ghia A" Remove constraint Author: "Ghia A"
8,937 results on '"Ghia A"'

Search Results

201. Observation of a Large-scale Anisotropy in the Arrival Directions of Cosmic Rays above $8 \times 10^{18}$ eV

202. Spectral Calibration of the Fluorescence Telescopes of the Pierre Auger Observatory

203. The Pierre Auger Observatory: Contributions to the 35th International Cosmic Ray Conference (ICRC 2017)

204. Muon Counting using Silicon Photomultipliers in the AMIGA detector of the Pierre Auger Observatory

205. Calibration of the Logarithmic-Periodic Dipole Antenna (LPDA) Radio Stations at the Pierre Auger Observatory using an Octocopter

206. Elicitation of societal preferences for chronic lymphocytic leukemia's treatments: a discrete choice experiment.

208. Stereotactic radiosurgery for prostate cancer spine metastases: local control and fracture risk using a simultaneous integrated boost approach.

209. Combined fit of spectrum and composition data as measured by the Pierre Auger Observatory

210. A targeted search for point sources of EeV photons with the Pierre Auger Observatory

211. Search for photons with energies above 10$^{18}$ eV using the hybrid detector of the Pierre Auger Observatory

213. Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

214. Management of Spine SBRT Adverse Effects

215. Genetic and phenotypic attributes of splenic marginal zone lymphoma

218. Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model

219. T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations

220. COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia

221. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

223. Cirmtuzumab Blocks Production of Proinflammatory Factors By Inhibiting Wnt5a/ROR1 Induced Activation of NF-Kappa B in Chronic Lymphocytic Leukemia

224. Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies.

225. Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies

226. Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2

227. Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia

228. Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study

229. Acalabrutinib Versus Investigator’s Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results

230. Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells

233. Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era—A Population-Based Observational Study

234. First‐line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age‐matched general population: A pooled post hoc analysis

235. The energy spectrum of cosmic rays beyond the turn-down around $$\varvec{10^{17}}$$ 10 17 eV as measured with the surface detector of the Pierre Auger Observatory

237. IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling

238. Pooled analysis of safety data from clinical trials evaluating acalabrutinib monotherapy in mature B-cell malignancies

239. Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations

240. Higher education expansion and graduate labour market outcomes in Spain : overqualification and its discontents

241. Multi-resolution anisotropy studies of ultrahigh-energy cosmic rays detected at the Pierre Auger Observatory

242. Testing Hadronic Interactions at Ultrahigh Energies with Air Showers Measured by the Pierre Auger Observatory

243. Evidence for a mixed mass composition at the `ankle' in the cosmic-ray spectrum

244. Search for ultrarelativistic magnetic monopoles with the Pierre Auger Observatory

245. Ultrahigh-energy neutrino follow-up of Gravitational Wave events GW150914 and GW151226 with the Pierre Auger Observatory

246. Measurement of the Radiation Energy in the Radio Signal of Extensive Air Showers as a Universal Estimator of Cosmic-Ray Energy

247. Prototype muon detectors for the AMIGA component of the Pierre Auger Observatory

248. The Pierre Auger Observatory Upgrade - Preliminary Design Report

249. Azimuthal asymmetry in the risetime of the surface detector signals of the Pierre Auger Observatory

250. Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study

Catalog

Books, media, physical & digital resources